In a conditional logistic regression model adjusted for disease duration, exposure to TNF inhibitors was associated with an increased risk of developing any inflammatory CNS events (adjusted OR, 3.01; 95% CI, 1.55-5.82; P = .001) in patients with all autoimmune diseases. Here, TNF is linked to autoimmune disease.